Cargando…

Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells

BACKGROUND: Doxorubicin (Dox) is an anti-cancer anthracycline drug that causes double-stranded DNA breaks. It is highly effective against several types of tumours; however, it also has adverse effects on regenerative populations of normal cells, such as human cardiac mesenchymal progenitor cells (hC...

Descripción completa

Detalles Bibliográficos
Autores principales: Beji, Sara, D’Agostino, Marco, Gambini, Elisa, Sileno, Sara, Scopece, Alessandro, Vinci, Maria Cristina, Milano, Giuseppina, Melillo, Guido, Napolitano, Monica, Pompilio, Giulio, Capogrossi, Maurizio C., Avitabile, Daniele, Magenta, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210386/
https://www.ncbi.nlm.nih.gov/pubmed/34134693
http://dx.doi.org/10.1186/s12915-021-01058-5
_version_ 1783709300133199872
author Beji, Sara
D’Agostino, Marco
Gambini, Elisa
Sileno, Sara
Scopece, Alessandro
Vinci, Maria Cristina
Milano, Giuseppina
Melillo, Guido
Napolitano, Monica
Pompilio, Giulio
Capogrossi, Maurizio C.
Avitabile, Daniele
Magenta, Alessandra
author_facet Beji, Sara
D’Agostino, Marco
Gambini, Elisa
Sileno, Sara
Scopece, Alessandro
Vinci, Maria Cristina
Milano, Giuseppina
Melillo, Guido
Napolitano, Monica
Pompilio, Giulio
Capogrossi, Maurizio C.
Avitabile, Daniele
Magenta, Alessandra
author_sort Beji, Sara
collection PubMed
description BACKGROUND: Doxorubicin (Dox) is an anti-cancer anthracycline drug that causes double-stranded DNA breaks. It is highly effective against several types of tumours; however, it also has adverse effects on regenerative populations of normal cells, such as human cardiac mesenchymal progenitor cells (hCmPCs), and its clinical use is limited by cardiotoxicity. Another known effect of Dox is nucleolar disruption, which triggers the ubiquitously expressed nucleolar phosphoprotein Nucleophosmin (NPM) to be released from the nucleolus into the cell, where it participates in the orchestration of cellular stress responses. NPM has also been observed in the extracellular space in response to different stress stimuli; however, the mechanism behind this and its functional implications are as yet largely unexplored. The aim of this study was to establish whether Dox could elicit NPM secretion in the extracellular space and to elucidate the mechanism of secretion and the effect of extracellular NPM on hCmPCs. RESULTS: We found that following the double-strand break formation in hCmPCs caused by Dox, NPM was rapidly secreted in the extracellular space by an active mechanism, in the absence of either apoptosis or necrosis. Extracellular release of NPM was similarly seen in response to ultraviolet radiation (UV). Furthermore, we observed an increase of NPM levels in the plasma of Dox-treated mice; thus, NPM release also occurred in vivo. The treatment of hCmPCs with extracellular recombinant NPM induced a decrease of cell proliferation and a response mediated through the Toll-like receptor (TLR)4. We demonstrated that NPM binds to TLR4, and via TLR4, and nuclear factor kappa B (NFkB) activation/nuclear translocation, exerts proinflammatory functions by inducing IL-6 and COX-2 gene expression. Finally, we found that in hCmPCs, NPM secretion could be driven by an autophagy-dependent unconventional mechanism that requires TLR4, since TLR4 inhibition dramatically reduced Dox-induced secretion. CONCLUSIONS: We hypothesise that the extracellular release of NPM could be a general response to DNA damage since it can be elicited by either a chemical agent such as Dox or a physical genotoxic stressor such as UV radiation. Following genotoxic stress, NPM acts similarly to an alarmin in hCmPCs, being rapidly secreted and promoting cell cycle arrest and a TLR4/NFκB-dependent inflammatory response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-021-01058-5.
format Online
Article
Text
id pubmed-8210386
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82103862021-06-17 Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells Beji, Sara D’Agostino, Marco Gambini, Elisa Sileno, Sara Scopece, Alessandro Vinci, Maria Cristina Milano, Giuseppina Melillo, Guido Napolitano, Monica Pompilio, Giulio Capogrossi, Maurizio C. Avitabile, Daniele Magenta, Alessandra BMC Biol Research Article BACKGROUND: Doxorubicin (Dox) is an anti-cancer anthracycline drug that causes double-stranded DNA breaks. It is highly effective against several types of tumours; however, it also has adverse effects on regenerative populations of normal cells, such as human cardiac mesenchymal progenitor cells (hCmPCs), and its clinical use is limited by cardiotoxicity. Another known effect of Dox is nucleolar disruption, which triggers the ubiquitously expressed nucleolar phosphoprotein Nucleophosmin (NPM) to be released from the nucleolus into the cell, where it participates in the orchestration of cellular stress responses. NPM has also been observed in the extracellular space in response to different stress stimuli; however, the mechanism behind this and its functional implications are as yet largely unexplored. The aim of this study was to establish whether Dox could elicit NPM secretion in the extracellular space and to elucidate the mechanism of secretion and the effect of extracellular NPM on hCmPCs. RESULTS: We found that following the double-strand break formation in hCmPCs caused by Dox, NPM was rapidly secreted in the extracellular space by an active mechanism, in the absence of either apoptosis or necrosis. Extracellular release of NPM was similarly seen in response to ultraviolet radiation (UV). Furthermore, we observed an increase of NPM levels in the plasma of Dox-treated mice; thus, NPM release also occurred in vivo. The treatment of hCmPCs with extracellular recombinant NPM induced a decrease of cell proliferation and a response mediated through the Toll-like receptor (TLR)4. We demonstrated that NPM binds to TLR4, and via TLR4, and nuclear factor kappa B (NFkB) activation/nuclear translocation, exerts proinflammatory functions by inducing IL-6 and COX-2 gene expression. Finally, we found that in hCmPCs, NPM secretion could be driven by an autophagy-dependent unconventional mechanism that requires TLR4, since TLR4 inhibition dramatically reduced Dox-induced secretion. CONCLUSIONS: We hypothesise that the extracellular release of NPM could be a general response to DNA damage since it can be elicited by either a chemical agent such as Dox or a physical genotoxic stressor such as UV radiation. Following genotoxic stress, NPM acts similarly to an alarmin in hCmPCs, being rapidly secreted and promoting cell cycle arrest and a TLR4/NFκB-dependent inflammatory response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-021-01058-5. BioMed Central 2021-06-16 /pmc/articles/PMC8210386/ /pubmed/34134693 http://dx.doi.org/10.1186/s12915-021-01058-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Beji, Sara
D’Agostino, Marco
Gambini, Elisa
Sileno, Sara
Scopece, Alessandro
Vinci, Maria Cristina
Milano, Giuseppina
Melillo, Guido
Napolitano, Monica
Pompilio, Giulio
Capogrossi, Maurizio C.
Avitabile, Daniele
Magenta, Alessandra
Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells
title Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells
title_full Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells
title_fullStr Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells
title_full_unstemmed Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells
title_short Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells
title_sort doxorubicin induces an alarmin-like tlr4-dependent autocrine/paracrine action of nucleophosmin in human cardiac mesenchymal progenitor cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210386/
https://www.ncbi.nlm.nih.gov/pubmed/34134693
http://dx.doi.org/10.1186/s12915-021-01058-5
work_keys_str_mv AT bejisara doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT dagostinomarco doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT gambinielisa doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT silenosara doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT scopecealessandro doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT vincimariacristina doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT milanogiuseppina doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT melilloguido doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT napolitanomonica doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT pompiliogiulio doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT capogrossimaurizioc doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT avitabiledaniele doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells
AT magentaalessandra doxorubicininducesanalarminliketlr4dependentautocrineparacrineactionofnucleophosmininhumancardiacmesenchymalprogenitorcells